Evan Lipson, MD
Disclosures: Consulting Fee-Bristol-Myers Squibb-Principal_Investigator|Contracted Research-Bristol-Myers Squibb-Principal_Investigator|Contracted Research-Merck and Company, Inc.-Principal_Investigator|Consulting Fee-Array BioPharma|Consulting Fee-EMD Serono|Consulting Fee-MacroGenics|Consulting Fee-Merck and Company, Inc.-Principal_Investigator|Contracted Research-Sysmex-Principal_Investigator|patent application: Method of preventing organ transplantation rejections using agonists to the PD-1 checkpoint pathway
No Bio Available.